# The PEERLESS Study

> **NCT05111613** · NA · COMPLETED · sponsor: **Inari Medical** · enrollment: 692 (actual)

## Conditions studied

- Pulmonary Embolism
- Pulmonary Thromboembolism

## Interventions

- **DEVICE:** Catheter-Directed Thrombolysis
- **DEVICE:** FlowTriever System

## Key facts

- **NCT ID:** NCT05111613
- **Lead sponsor:** Inari Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-14
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-04-11
- **Target enrollment:** 692 (ACTUAL)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111613, "The PEERLESS Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05111613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*